AI is already inside your clinical workflows.
The question is who governs it.
Falkovia designs the clinical authority structures, decision rights, and override protocols that healthcare leadership teams need before regulatory or patient safety events force the question.
State AI healthcare legislation is accelerating. CMS is developing oversight requirements. And board members are asking harder questions about AI adoption without always having the expertise to evaluate the answers. Some healthcare leaders want a trusted partner who keeps them current on what is happening, translates what new regulatory developments mean for their system, and makes sure they walk into every board and committee conversation prepared. That is the work this practice was built around. The moment a leader walks into that room knowing exactly what to say.
Explore The Intelligence LayerThe healthcare AI governance gap
AI is embedded in clinical workflows, diagnostic support, documentation, scheduling, and revenue cycle management across healthcare systems. Much of it was adopted without formal governance approval. Some of it was never evaluated for patient safety implications. Almost none of it has documented decision authority or override protocols.
The governance gap is not theoretical. State legislatures are passing AI-specific healthcare regulations. CMS is developing AI oversight requirements. Accreditation bodies are issuing AI governance standards. And the plaintiff's bar is already building cases around AI-driven healthcare decisions that lacked documented human oversight.
The question for healthcare leadership is not whether to adopt AI. It is whether the governance architecture exists to make every AI-assisted decision in your system defensible: to your board, your regulators, your accreditors, and a jury.
Dr. Masson brings expertise in the integration of AI into modern healthcare delivery models.
— Healthcare Executive
Dr. Masson brings a detail-oriented approach to translating complex problems into practical, innovative solutions.
— Healthcare Executive
of healthcare organizations report AI tools in active use that were never formally approved through governance channels
states have introduced or passed AI-specific healthcare legislation since 2023
of clinicians report using AI tools on personal devices or accounts outside institutional oversight
Five questions every healthcare CEO should be able to answer
Decision rights
Who in your organization has the documented authority to approve, restrict, or prohibit AI use in clinical workflows, diagnostics, and patient-facing operations?
Override authority
When an AI-assisted clinical decision is wrong, is there a documented protocol for clinician override, and is it structurally embedded in the workflow, or dependent on individual judgment in the moment?
Shadow AI exposure
How many AI tools are being used across your system right now that were never formally approved, evaluated for patient safety, or documented in your governance architecture?
Regulatory defensibility
If a state regulator, CMS auditor, or accreditation body asked to see your AI governance documentation tomorrow, what would you hand them?
Incident response readiness
If an AI-assisted clinical decision led to a patient safety event tonight, does your organization have a documented response protocol, or would leadership be designing one in the middle of a crisis?
What the engagement produces
Discovery & Assessment
Understanding where you stand
Shadow AI Audit
Complete inventory of AI tools in use across clinical, operational, and administrative domains, including tools adopted without formal governance approval.
G.U.A.R.D. Framework Assessment
Governance, Use authority, Accountability, Risk management, and Documentation framework customized to your institution's regulatory and accreditation environment.
Decision Authority Map
Role-by-role documentation of who holds authority to approve, restrict, override, and prohibit AI use across every institutional domain.
Architecture & Protocols
Building the governance infrastructure
Human Authority Line
Documented mapping of where human clinical judgment must remain non-delegable, by system, by workflow, by risk level.
Override and Escalation Protocols
Documented protocols for clinician override of AI-assisted decisions, including escalation paths and accountability structures.
Board Governance Charter
Board-ready AI governance charter defining oversight responsibilities, reporting requirements, and fiduciary accountability structures.
Regulatory Alignment Documentation
Baseline mapping of governance architecture to current state AI legislation, CMS requirements, Joint Commission standards, and applicable federal frameworks.
HIPAA and Privacy Architecture
AI-specific privacy and data governance protocols aligned with HIPAA requirements and institutional data handling standards.
Operationalization
Making it work from day one
Incident Response Protocol
Documented protocol for AI-related patient safety events, regulatory inquiries, and public-facing incidents with named accountability and response timelines.
Implementation Roadmap
Phased implementation plan with accountability assignments, milestones, and governance maturity benchmarks.
Who this engagement serves
CEOs and COOs
Accountable for institutional AI governance and responsible for ensuring the organization's AI adoption does not create regulatory, legal, or patient safety exposure that reaches the board.
Chief Medical Officers
Responsible for clinical quality and patient safety across AI-assisted workflows, diagnostics, and documentation, and accountable when AI-related clinical decisions are questioned.
General Counsel
Managing legal exposure from AI-assisted clinical decisions, regulatory compliance obligations, and the growing landscape of state AI legislation and litigation.
Compliance and Risk Officers
Responsible for regulatory compliance, accreditation readiness, and risk management across an AI landscape that is evolving faster than most compliance frameworks can track.
Board Members
Exercising fiduciary oversight of AI adoption without operational visibility into how AI is being used in clinical workflows, who approved it, or whether governance structures exist to manage it.
Frequently Asked Questions
A compliance audit tests whether you meet a defined standard. A Falkovia engagement designs the human governance architecture underneath that standard: who holds clinical override authority, where the Human Authority Line is drawn for each AI-assisted workflow, and how your organization responds in the first 90 minutes of an AI-related patient safety event. Compliance frameworks assume the architecture exists. Falkovia builds it.
No. Most engagements begin after AI is already in active clinical use. The Shadow AI Audit and decision authority mapping are designed precisely for organizations whose AI footprint has outpaced their governance architecture. The earlier the governance work begins, the less reactive it has to be when regulators or accreditors ask the question.
G.U.A.R.D. stands for Governance, Use Authority, Accountability, Risk Management, and Documentation. It is one of several structured instruments Falkovia applies in healthcare engagements. The full assessment includes the AI Governance Maturity Index, the AI Adoption Risk Index, a Shadow AI Audit, and the AI Governance Framework for Hospital Boards, alongside a 50+ question diagnostic mapped to NIST AI RMF, ISO/IEC 42001, and the EU AI Act. Together they produce a documented governance architecture customized to your organization's regulatory environment, accreditation status, and current AI exposure.
Both. The governance architecture is sector-specific, not size-specific. Academic medical centers carry additional research and IRB considerations; community systems often carry more shadow AI exposure because deployment moved faster than central oversight. The engagement is scoped to the organization's actual governance landscape.
The architecture is designed to integrate with, not replace, existing medical staff governance. Falkovia maps where AI-related clinical decisions intersect with credentialing, peer review, and quality oversight structures, and produces governance documentation that medical staff leadership can adopt without rewriting their bylaws.
Yes. Multi-state systems are one of the most common engagement profiles. The regulatory mapping is built into the engagement, including Texas TRAIGA, Colorado's AI Act, and the growing patchwork of state-level healthcare AI legislation. The governance architecture is designed to hold across the strictest applicable standard.
Next Step
Your clinicians are already using AI. The governance question is whether your health system is ready for what happens next.
Every engagement begins with a confidential conversation about what your health system actually needs.
Start a Confidential Conversation